| Primary |
| Product Used For Unknown Indication |
53.8% |
| Drug Use For Unknown Indication |
26.9% |
| Hypothyroidism |
15.4% |
| Parkinson's Disease |
3.8% |
|
| Hypothyroidism |
40.0% |
| Toxic Skin Eruption |
40.0% |
| Vomiting |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
50.0% |
| Drug Use For Unknown Indication |
30.0% |
| Hypothyroidism |
15.0% |
| Epilepsy |
5.0% |
|
| Hypothyroidism |
40.0% |
| Talipes |
20.0% |
| Toxic Skin Eruption |
20.0% |
| Ventricular Septal Defect |
20.0% |
|
| Concomitant |
| Rheumatoid Arthritis |
19.2% |
| Product Used For Unknown Indication |
17.3% |
| Drug Use For Unknown Indication |
11.6% |
| Hypothyroidism |
8.4% |
| Back Pain |
7.0% |
| Hypertension |
4.7% |
| Breast Cancer |
3.8% |
| Mineral Supplementation |
3.5% |
| Metastases To Bone |
3.2% |
| Constipation Prophylaxis |
2.3% |
| Sleep Disorder Therapy |
2.3% |
| Pain |
2.2% |
| Depression |
2.1% |
| Constipation |
1.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.9% |
| Diabetes Mellitus |
1.8% |
| Diarrhoea |
1.8% |
| Thyroid Cancer |
1.8% |
| Crohn's Disease |
1.6% |
| Pulmonary Arterial Hypertension |
1.6% |
|
| Tuberculosis |
10.4% |
| Vomiting |
10.4% |
| Therapeutic Response Decreased |
9.4% |
| Colon Cancer |
8.3% |
| Pyrexia |
7.3% |
| Intestinal Obstruction |
6.3% |
| Cardiomyopathy Alcoholic |
4.2% |
| Rash |
4.2% |
| Septic Shock |
4.2% |
| Supraventricular Extrasystoles |
4.2% |
| Acute Febrile Neutrophilic Dermatosis |
3.1% |
| Anal Abscess |
3.1% |
| Blood Lactate Dehydrogenase Increased |
3.1% |
| Metastatic Squamous Cell Carcinoma |
3.1% |
| Myocardial Infarction |
3.1% |
| Respiratory Distress |
3.1% |
| Skin Lesion |
3.1% |
| Thrombocytopenia |
3.1% |
| Tinnitus |
3.1% |
| Tooth Extraction |
3.1% |
|
